EGFR and lung cancer: To check whether an IR-induced G2 checkpoint defect is specific for TrkA/NTRK1 or is a general consequence of tyrosine kinase activation in cancer cells, we used EGFR-overexpressing lung cancer cells, A549 and H1975, as a control.